Trial
NCT01673984
GP Extended Action Triptorelin
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Ipsen
Collaborators
—
Condition
Prostate Cancer
Intervention
Decapeptyl® SR 22.5mg
Why stopped
The study was discontinued prematurely by the sponsor due to non-medical reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-23